Eli Lilly (LLY) Expands Portfolio with Clazakizumab Deal, Reuters Reports
Eli Lilly and Company (NYSE:LLY) is included among the 16 Best Dividend Stocks with Growing Payouts. Eli Lilly (LLY) Expands Portfolio with Clazakizumab Deal, Reuters Reports According to a Reuters report on Feb. 18, Australia’s CSL said it had granted Eli Lilly and Company (NYSE:LLY) certain rights to develop and commercialize clazakizumab, an anti-interleukin-6 monoclonal…